檢索結果 - Jing‐Quan Wang

  • Showing 1 - 14 results of 14
Refine Results
  1. 1
    Features of Cytokine Storm Identified by Distinguishing Clinical Manifestations in COVID-19

    Features of Cytokine Storm Identified by Distinguishing Clinical Manifestations in COVID-19 由 Weixi Shen, Rongcheng Luo, Jing‐Quan Wang, Zhe‐Sheng Chen

    出版 2021
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    RNA methylation and cancer treatment

    RNA methylation and cancer treatment 由 Baochen Yang, Jing‐Quan Wang, Yao Tan, Runzhu Yuan, Zhe‐Sheng Chen, Chang Zou

    出版 2021
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  3. 3
    Anti-Bacterial and Anti-Inflammatory Properties of Sophoridine and Its Effect on Diarrhea in Mice

    Anti-Bacterial and Anti-Inflammatory Properties of Sophoridine and Its Effect on Diarrhea in Mice 由 Jiaxue Wang, Hui Tao, Qiuyu Fan, Zhenlong Wang, Bing Han, Xiumin Wang, Jing‐Quan Wang

    出版 2025
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    The AKT inhibitor, MK-2206, attenuates ABCG2-mediated drug resistance in lung and colon cancer cells

    The AKT inhibitor, MK-2206, attenuates ABCG2-mediated drug resistance in lung and colon cancer cells 由 Hailing Gao, Qingbin Cui, Jing‐Quan Wang, Charles R. Ashby, Yanchun Chen, Zhixin Shen, Zhe‐Sheng Chen

    出版 2023
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Olmutinib (BI1482694/HM61713), a Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses ABCG2-Mediated Multidrug Resistance in Cancer Cells

    Olmutinib (BI1482694/HM61713), a Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses ABCG2-Mediated Multidrug Resistance in Cancer Cells 由 Wei Zhang, Yingfang Fan, Chao‐Yun Cai, Jing‐Quan Wang, Qiu‐Xu Teng, Zi‐Ning Lei, Leli Zeng, Pranav Gupta, Zhe‐Sheng Chen

    出版 2018
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Selonsertib (GS-4997), an ASK1 inhibitor, antagonizes multidrug resistance in ABCB1- and ABCG2-overexpressing cancer cells

    Selonsertib (GS-4997), an ASK1 inhibitor, antagonizes multidrug resistance in ABCB1- and ABCG2-overexpressing cancer cells 由 Ning Ji, Yuqi Yang, Chao‐Yun Cai, Zi‐Ning Lei, Jing‐Quan Wang, Pranav Gupta, Suneet Shukla, Suresh V. Ambudkar, Dexin Kong, Zhe‐Sheng Chen

    出版 2018
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    VS-4718 Antagonizes Multidrug Resistance in ABCB1- and ABCG2-Overexpressing Cancer Cells by Inhibiting the Efflux Function of ABC Transporters

    VS-4718 Antagonizes Multidrug Resistance in ABCB1- and ABCG2-Overexpressing Cancer Cells by Inhibiting the Efflux Function of ABC Transporters 由 Ning Ji, Yuqi Yang, Chao‐Yun Cai, Zi‐Ning Lei, Jing‐Quan Wang, Pranav Gupta, Qiu‐Xu Teng, Zhe‐Sheng Chen, Dexin Kong, Dong‐Hua Yang

    出版 2018
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Venetoclax, a BCL-2 Inhibitor, Enhances the Efficacy of Chemotherapeutic Agents in Wild-Type ABCG2-Overexpression-Mediated MDR Cancer Cells

    Venetoclax, a BCL-2 Inhibitor, Enhances the Efficacy of Chemotherapeutic Agents in Wild-Type ABCG2-Overexpression-Mediated MDR Cancer Cells 由 Jing‐Quan Wang, Jonathan Y. Li, Qiu‐Xu Teng, Zi‐Ning Lei, Ning Ji, Qingbin Cui, Leli Zeng, Yihang Pan, Dong‐Hua Yang, Zhe‐Sheng Chen

    出版 2020
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    Erdafitinib Antagonizes ABCB1-Mediated Multidrug Resistance in Cancer Cells

    Erdafitinib Antagonizes ABCB1-Mediated Multidrug Resistance in Cancer Cells 由 Weiguo Feng, Meng Zhang, Zhuo‐Xun Wu, Jing‐Quan Wang, Xing-Duo Dong, Yuqi Yang, Qiu‐Xu Teng, Xuan-Yu Chen, Qingbin Cui, Dong‐Hua Yang

    出版 2020
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    Microbiota in health and diseases

    Microbiota in health and diseases 由 Kejun Hou, Zhuo‐Xun Wu, Xuan-Yu Chen, Jing‐Quan Wang, Dongya Zhang, Chuanxing Xiao, Dan Zhu, Jagadish Koya, Liuya Wei, Jilin Li, Zhe‐Sheng Chen

    出版 2022
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  11. 11
    Sunitinib resistance in renal cell carcinoma: From molecular mechanisms to predictive biomarkers

    Sunitinib resistance in renal cell carcinoma: From molecular mechanisms to predictive biomarkers 由 Juan Jin, Yuhao Xie, Jin-Shi Zhang, Jing‐Quan Wang, Shi-Jie Dai, Wenfang He, Shou-Ye Li, Charles R. Ashby, Zhe‐Sheng Chen, He Qiang

    出版 2023
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  12. 12
    Tetrandrine Interaction with ABCB1 Reverses Multidrug Resistance in Cancer Cells Through Competition with Anti-Cancer Drugs Followed by Downregulation of ABCB1 Expression

    Tetrandrine Interaction with ABCB1 Reverses Multidrug Resistance in Cancer Cells Through Competition with Anti-Cancer Drugs Followed by Downregulation of ABCB1 Expression 由 Dan Liao, Wei Zhang, Pranav Gupta, Zi‐Ning Lei, Jing‐Quan Wang, Chao‐Yun Cai, Albert A. De Vera, Lei Zhang, Zhe‐Sheng Chen, Dong‐Hua Yang

    出版 2019
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    Sitravatinib, a Tyrosine Kinase Inhibitor, Inhibits the Transport Function of ABCG2 and Restores Sensitivity to Chemotherapy-Resistant Cancer Cells in vitro

    Sitravatinib, a Tyrosine Kinase Inhibitor, Inhibits the Transport Function of ABCG2 and Restores Sensitivity to Chemotherapy-Resistant Cancer Cells in vitro 由 Yuqi Yang, Ning Ji, Qiu‐Xu Teng, Chao‐Yun Cai, Jing‐Quan Wang, Zhuo‐Xun Wu, Zi‐Ning Lei, Sabrina Lusvarghi, Suresh V. Ambudkar, Zhe‐Sheng Chen

    出版 2020
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    Tivantinib, A c-Met Inhibitor in Clinical Trials, Is Susceptible to ABCG2-Mediated Drug Resistance

    Tivantinib, A c-Met Inhibitor in Clinical Trials, Is Susceptible to ABCG2-Mediated Drug Resistance 由 Zhuo‐Xun Wu, Yuqi Yang, Qiu‐Xu Teng, Jing‐Quan Wang, Zi‐Ning Lei, Jing-Qiu Wang, Sabrina Lusvarghi, Suresh V. Ambudkar, Dong‐Hua Yang, Zhe‐Sheng Chen

    出版 2020
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: